Follow the entities shaping the evidence.

…ral was 116 (9-263) days. Three patients were on treatment with tafamidis, 6 were awaiting appointment and 1 was diagnosed with AL amyloi…

…Background It is well-recognised that ischaemic heart disease remains the major leading cause of morbidity and mortality in p…

…pre-eclampsia, and three patients had diabetes mellitus (one on insulin). Nine mothers were clinically overweight, and five had a BMI o…

…Introduction In patients with cardiac sarcoidosis (CS), recent evidence suggests that non-sustained ventricular t…

… were achieved. Repeat conduction indices were measured, and an atropine test was performed before procedure conclusion. Amongst the con…

…h individual and combination LLT, including statins, ezetimibe, bempedoic acid, and PCSK9 inhibitors. Admission lipid profile and pre-ACS LLT …

…Background Early cancer diagnosis significantly improves treatment outcomes and surviva…

… surfactant administration method will be used for infants with respiratory distress syndrome to avoid intubation whenever possible. Infants intubated at bir…

…e between T6 and T12 (81%), corresponding to 73% of the largest MD location. CVFs originated in 19% at and in 53% within ±2 bilate…

…, mean age at diagnosis was 54+/-16 (table 1). The incidence of SSc was in average 3.85 per 100,000 person-years. The mean prevalen…

… (HR 0.49; 95% CI:0.36-0.67, p<0.001) (figure 2).Conclusions In lcSSc, clinically meaningful progression, defined by MINIMISE endpoin…

…Sc with secondary RP (mean PRS primary RP: -3.51E-3 vs mean PRS SSc with secondary RP: 7.01E-5; p-value = 7.52E-3), indicating that…